Journal of Solid Tumors (JST) is an open access, peer-reviewed international journal that considers articles on all aspects of cancer research. The journal welcomes submissions concerning the molecular and cell biology of solid tumors, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. Randomized controlled trials, especially phase III trials and evidence-based meta-analysis or pooled analysis related to specific trials are preferred clinical papers. The primary criterion for publication is interest to a multidisciplinary audience.
The articles of JST are indexed in:
- Google Scholar
- PKP Open Archives Harvester
- The Standard Periodical Directory
The journal is published in both print and online versions. The online version is free to access and download.
To facilitate rapid publication and to minimize administrative costs, the journal accepts Online submission and Email submission. All manuscripts and any supplementary material can be submitted via the journal’s Online Submission and peer-review system or email to email@example.com. For online submission, please create a new account and then follow the instructions given on the screen.
Original Research, Case Reports, Reviews.
2015 Q2: Articles Received: 12; Accepted: 8; Rejected: 3; Published: 8; Retracted: 0
2015 Q1: Articles Received: 6; Accepted: 6; Rejected: 3; Published: 10; Retracted: 0
2014: Articles Received: 32; Accepted: 20; Rejected: 8; Published: 10; Retracted: 1
2013: Articles Received: 74; Accepted: 42; Rejected: 39; Published: 10; Retracted: 1
What is e-Version FirstTM
e-Version First is a feature offered through our journal platform. It allows PDF version of manuscripts that have been peer reviewed and accepted, to be hosted online prior to their inclusion in a final printed journal. Readers can freely access or cite the article. We aim to publish accepted manuscripts in e-Version First in two week's time after the final draft completed.
Paper Selection and Publication Process
a) Upon receipt of paper submission, the Editor sends an E-mail of confirmation to the corresponding author within 1-3 working days. If you fail to receive this confirmation, your submission/e-mail may be missed. Please contact the Editor in time for that.
b) Peer review. We use double-blind system for peer-review; both reviewers and authors' identities remain anonymous. The paper will be peer-reviewed by three experts; two reviewers from outside and one editor from the journal typically involve in reviewing a submission. The review process may take 2-3 weeks.
c) Notification of the result of review by E-mail.
d) The authors revise paper and pay publication fee (200.00 USD).
e) After publication, the corresponding author will receive the copy of printed journal, free of charge.
f) E-journal in PDF is available on the journal’s webpage, free of charge for download.
The publisher and journal have a policy of “Zero Tolerance on the Plagiarism”. We check the plagiarism issue through two methods: reviewer check and plagiarism prevention tool (ithenticate.com).
All submissions will be checked by iThenticate before being sent to reviewers.
Call for Papers--Journal of Solid Tumors
|We are calling for papers for Journal of Solid Tumors. If you have suitable manuscripts about oncology research, please don't hesitate to submit them to: firstname.lastname@example.org|
Vol 5, No 2 (2015)
Table of Contents
|Rhabdomyosarcoma in adolescents: A CCHE experience|
|Emad A.H Moussa, Enas El Nadi, Hosam El Zomor, Hanafy Ahmed Hafez, Alaa Younes, Hala Taha, Naglaa EL-Kenanii, Mohamed S. Zaghloul, Madeha El-Wekeel, Rania M. Labib, Marwa Tantawy||p1|
|Irreversible electroporation of malignant lesions: An institution experience|
|Benjamin J. Bates, Minia Hellan, Shannon Kauffman, James Ouellette||p11|
|PET/CT and MIBG scans in diagnosis and management of Neuroblastoma|
|Mohamed Fawzy, Emad Moussa, Asmaa Hamouda, Ahmed Zaher, Omneya Hassanein, Sara Azmy||p32|
|Expressions of Aquaporin4, VEGFR1 and the pattern of genetic aberrations in meningiomas have no influence on the peritumoral edema|
|Stefan Linsler, David Reuss, Markus Klotz, Karl-Herbert Schaefer, Joachim Oertel, Ralf Ketter, Steffi Urbschat||p40|
|Continuous chemoradiation following complete response to neo-adjuvant chemotherapy provides improved outcomes in muscle invasive urothelial carcinoma|
|Javier Lopez Araujo, Rojymon Jacob, Craig Baden, John B. Fiveash, Michael Dobelbower, James E. Bryant, Graeme B. Bolger||p59|
|Anticancer activity of a novel quinazolinone-chalcone derivative through cell cycle arrest in pancreatic cancer cell line|
|Zahoor A. Wani, Anup S. Pathania, Girish Mahajan, Akanksha Behl, Mubashir J. Mintoo, Santosh K. Guru, A. Viswanath, Fayaz Malik, Ahmed Kamal, Dilip M. Mondhe||p73|
|Real world experience with dose dense ac-paclitaxel: Two canadian cancer centers’ experience|
|Emad Tashkandi, Michael Yan, Jawaid Younus, MA Jawaid, Caroline Hamm, Swati Kulkarni, Rasna Gupta, John Matthews, Tarek Elfiki, Larry Stitt||p86|
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt|
|Enas El-Nadi, Hossam Elzomor, Rania M. Labib, Ahmad S. Alfaar, Mohamed S. Zaghloul, Hala Taha, Alaa Younes, Madeeha Elwakeel||p94|
|Irinotecan and temozolomide in adults with recurrent sarcoma|
|Phillip S. Blanchette, Aaron Lo, Pamela Ng, Albiruni Razak, Eitan Amir, David Hogg, Martin E. Blackstein, Abha A. Gupta||p105|
|Metastatic adamantinoma responds to treatment with receptor tyrosine kinase and Aurora A kinase inhibitor|
|Imran Unal, Odile David, Arkadiusz Z. Dudek||p27|
|Bullous pemphigoid appearing as superficial tissue necrosis after irradiation of the breast: Case history and definitive review of the literature|
|Mark Gerard Trombetta, Kathleen Erb, Vijay Kudithipudi, Judith Small||p53|
|Liposarcoma arising from the right renal sinus with inferior vena caval involvement|
|Yasuyuki Kobayashi, Masashi Nakayama, Kyosuke Matsuzaki, Ken Takeda, Takahiro Yoshida, Yasuyuki Arai, Kenichi Kakimoto, Michiko Yuki, Yasuhiko Tomita, Yutaka Ono, Kazuo Nishimura||p69|
|Hepatocellular carcinoma treatment strategies – a case-based review|
|Rute Alves, Manuel Teixeira Gomes, Carlos Sampaio Macedo, Helena P. Miranda, Filipe Nery||p120|
|The recent progress of neoadjuvant chemotherapy in triple negative breast cancer: A short review|
|Michalis Liontos, Sophia Karageorgopoulou, Vasiliki Michalaki, John Contis, Evangelos Bournakis, John Vassiliou, Meletios-Athanasios Dimopoulos, Christos A. Papadimitriou||p18|
|HPV prophylactic vaccines: Second-generation or first-generation vaccines|
|Kimia Kardani, Golnaz Mardani, Azam Bolhassani||p112|
This work is licensed under a Creative Commons Attribution 3.0 License.
Journal of Solid Tumors
ISSN 1925-4067(Print) ISSN 1925-4075(Online)
Copyright © Sciedu Press
To make sure that you can receive messages from us, please add the 'Sciedupress.com' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.